Opioid Poorly-Responsive Cancer Pain. Part 2: Basic Mechanisms That Could Shift Dose Response for Analgesia
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 21 (3) , 255-264
- https://doi.org/10.1016/s0885-3924(00)00236-0
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Opioid Poorly-Responsive Cancer Pain. Part 1: Clinical ConsiderationsJournal of Pain and Symptom Management, 2001
- The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the ratPain, 1996
- N-methyl-d-aspartate receptors and painCurrent Opinion In Anesthesiology, 1995
- Morphine Selectively Depresses the Slowest, NMDA‐independent Component of C‐fibre‐evoked Synaptic Activity in the Rat Spinal Cord In VitroEuropean Journal of Neuroscience, 1995
- Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teethPain, 1993
- Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic painPain, 1993
- Activity-dependent neuronal plasticity following tissue injury and inflammationTrends in Neurosciences, 1992
- Differences in Efficacies Between Morphine and Methadone Demonstrated in the Guinea Pig Ileum: A Possible Explanation for Previous Observations on Incomplete Opioid Cross‐ToleranceBasic & Clinical Pharmacology & Toxicology, 1989
- Role of adrenal glucocorticoids in the blockade of the development of analgesic tolerance to morphine by footshock stress exposure in mice.The Japanese Journal of Pharmacology, 1989
- Glucocorticoid suppression of the sympathetic nervous system and adrenal medullaLife Sciences, 1986